Probing the Binding Site in the Antibiotic Resistance Enzyme, AmpC β-lactamase
β-lactam drugs, such as penicillins and cephalosporins, are widely used to treat bacterial infections, but resistance to these drugs is increasingly becoming a problem. One of the main causes of resistance to these β-lactam drugs is the bacterial production of β-lactamase enzymes, such as AmpC. These enzymes are capable of breaking down the drug within their active sites, rendering the antibiotic unable to harm the bacteria. The exact roles that the active site amino acid residues play in the recognition and breakdown of the drug are not fully understood. Here, we investigate the role of the active site residue asparagine-152 (Asn152) in AmpC by mutating it to a glycine, serine, or threonine residue and examining the effect that these mutations have on kinetic and structural properties. Uncovering the specific role of Asn152 in the function of AmpC will be useful in the development of inhibitors to these enzymes in order to combat bacterial resistance.
Faculty Mentor: Brad Wallar, Chemistry
Page last modified July 16, 2012